XOMA Royalty Corp.
NASDAQ:XOMABiotechnology
Healthcare
$40.17 +0.44%
+$0.19 today
- Market cap
- $503.77M
- Beta
- 0.87
- P/E (TTM)
- 15.8
- EPS (TTM)
- $2.65
52W Low $22.29High $42.81
Volume 4.22M
Average 0.21M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$2.87M
FY 2025 · Annual
Investing Cash Flow
$50.89M
FY 2025 · Annual
Financing Cash Flow
-$26.46M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 15.8M | (17.1M) | (40.83M) | (13.82M) | 31.71M |
| Depreciation & Amortization | 7K | 104K | 900K | 216K | 2.97M |
| Deferred Income Tax | 0 | 0 | 0 | (5.66M) | 103K |
| Stock-Based Compensation | 6.2M | 3.61M | 9.1M | 10.31M | 9.27M |
| Change in Working Capital | (886K) | (181K) | (3.53M) | (2.79M) | (11.37M) |
| Accounts Receivables | 1.58M | 208K | (1M) | (835K) | (2.43M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 765K | 1.85M | (523K) | 1.6M | (10.6M) |
| Other Working Capital | (3.23M) | (2.23M) | (2M) | (3.55M) | 1.65M |
| Other Non-Cash Items | 1.56M | 694K | 16.2M | (2.01M) | (29.82M) |
| Operating Cash Flow | 22.68M | (12.88M) | (18.16M) | (13.75M) | 2.87M |
| Capital Expenditures | (26.5M) | (15.25M) | (17K) | (20K) | 0 |
| Acquisitions (Net) | 0 | 0 | 0 | (1.25M) | 3.85M |
| Purchases of Investments | 0 | 0 | 0 | (3.24M) | (99K) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (26.5M) | (4.97M) | (694K) | (23.75M) | 47.14M |
| Investing Cash Flow | (26.5M) | (20.22M) | (711K) | (28.26M) | 50.89M |
| Debt Repayment | (4.25M) | 0 | 130M | (6.9M) | (10.6M) |
| Common Stock Issued | 1.58M | 2.42M | 466K | 5.21M | 8.72M |
| Common Stock Repurchased | 0 | 0 | (148K) | (13K) | (16.04M) |
| Dividends Paid | (3.5M) | (5.47M) | (5.47M) | (5.47M) | (5.47M) |
| Other Financing Activities | (21M) | (1.4M) | (3.79M) | 1.26M | (3.07M) |
| Financing Cash Flow | 12.84M | (4.45M) | 120.59M | (11.13M) | (26.46M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 9.01M | (37.55M) | 101.72M | (53.13M) | 27.29M |
| Free Cash Flow | (3.82M) | (28.13M) | (18.18M) | (13.77M) | 2.87M |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income$31.7M
+ D&A$3.0M
+ Stock-Based Comp$9.3M
+ Deferred Tax$103.0K
- Working Capital-$11.4M
- Other Non-Cash-$29.8M
= Operating Cash Flow$2.9M
- Capex$0
= Free Cash Flow$2.9M
Analysis
FY2025 free cash flow is $2.9M. FCF conversion is 9.1% of net income. Operating cash flow was $2.9M, with capex of $0. The largest bridge item is Other Non-Cash at -$29.8M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| DEFA14A | DEFA14A filing | Jun 12, 2026 | |
| 8-K | Current report | Jun 12, 2026 | |
| DEFM14A | DEFM14A filing | Jun 10, 2026 | |
| 4 | Statement of changes in beneficial ownership | May 26, 2026 | |
| 4 | Statement of changes in beneficial ownership | May 26, 2026 |
Does XOMA generate free cash flow?
XOMA Royalty Corp. (XOMA) generated $2.87M of free cash flow in fiscal 2025.
How much operating cash flow does XOMA produce?
Operating cash flow was $2.87M, before capital expenditures of $0.00.
Continue the stock analysis
Jump to another research area for this company.